Cargando…

Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome

OBJECTIVE: To evaluate racial differences in the anxiety and depression prevalence and scores in women with polycystic ovary syndrome (PCOS). DESIGN: Cross-sectional. SETTING: Academic institution. PATIENT(S): Reproductive-aged women with PCOS (n = 272) and controls (n = 295). INTERVENTION(S): Hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alur-Gupta, Snigdha, Lee, Iris, Chemerinski, Anat, Liu, Chang, Lipson, Jenna, Allison, Kelly, Gallop, Robert, Dokras, Anuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267396/
https://www.ncbi.nlm.nih.gov/pubmed/34278359
http://dx.doi.org/10.1016/j.xfre.2021.03.003
Descripción
Sumario:OBJECTIVE: To evaluate racial differences in the anxiety and depression prevalence and scores in women with polycystic ovary syndrome (PCOS). DESIGN: Cross-sectional. SETTING: Academic institution. PATIENT(S): Reproductive-aged women with PCOS (n = 272) and controls (n = 295). INTERVENTION(S): Hospital anxiety and depression scale and modified PCOS quality-of-life survey (MPCOS-Q). MAIN OUTCOME MEASURE(S): Differences in depression and anxiety scores and quality-of-life score measured using the hospital anxiety and depression scale and MPCOS-Q were determined between White and Black women with PCOS. Multivariable correlation regressions assessed the association of the Ferriman-Gallwey score, total testosterone, body mass index (BMI), and homeostatic model assessment of insulin resistance with anxiety, depression, and quality-of-life scores. RESULT(S): Multivariable regression controlling for age, BMI, and socioeconomic status showed that White women with PCOS had a significantly higher prevalence of anxiety than Black women with PCOS (75.9% vs. 61.3%) and significantly higher anxiety scores (mean ± SD, 10.3 ± 4.1 vs. 8.7 ± 4.6). The prevalence of depression (24.4% vs. 29%) and depression scores (4.8 ± 3.6 vs. 5.1 ± 4.0) was not significantly different. In multivariable correlation regressions, the interaction between BMI and race in its association with anxiety scores was significant. The association of race with Ferriman-Gallwey score, total testosterone, or homeostatic model assessment of insulin resistance was not significant. In multivariable models, although the total MPCOS-Q scores were similar, the infertility domain was significantly lower in Black women with PCOS (mean ± SD, 12.6 ± 7.8 vs. 17.5 ± 6.8) indicating a lower quality of life related to infertility. CONCLUSION: Racial differences identified in the prevalence of anxiety and MPCOS-Q domains suggest the importance of routine screening and provide an opportunity for targeted interventions based on race.